Jubilant Pharmova Limited has intimated the stock exchanges about a scheduled meeting of its Board of Directors. The meeting is set to occur on Friday, November 13, 2026.
The primary purpose of this board meeting is to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026.
This disclosure is made in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
The company confirmed that the financial results document will be simultaneously posted on the Company's official website at www.jubilantpharmova.com following the board meeting.
The communication was signed and digitally verified by Naresh Kapoor, who holds the position of Company Secretary at Jubilant Pharmova Limited.